Document Detail


Cryptococcosis in renal transplant patients.
MedLine Citation:
PMID:  801056     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
First, cryptococcal infections in transplant patients can be readily diagnosed and successfully treated; aggressive, innovative uses of currently available drugs should accomplish this. Second, some drug related toxicity, mostly nephrotoxicity and hematologic, is inevitable, and patients must be carefully monitored so that these effects may be minimized. Third, anti-fungal drug assays are available and can be performed and drug levels should be monitored, with the object of obtaining levels which are both reasonably safe and maximally effective in terms of known in vitro susceptibilities of the offending pathogen.
Authors:
M Tipple; H Haywood; S Shadomy; H M Lee; R J Duma
Related Documents :
12625926 - Entomological monitoring of annual mass drug administrations for the control or elimina...
19763106 - New approaches to drug safety: a pharmacovigilance tool kit.
8104096 - Bruxism secondary to chronic antidopaminergic drug exposure.
19998526 - Exploratory safety pharmacology: a new safety paradigm to de-risk drug candidates prior...
23991236 - In vivo imaging of trypanosome-brain interactions and development of a rapid screening ...
23770226 - Mathematical modeling of drug release from nanostructured porous si: combining carrier ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Proceedings of the Clinical Dialysis and Transplant Forum     Volume:  6     ISSN:  0094-6044     ISO Abbreviation:  Proc Clin Dial Transplant Forum     Publication Date:    1976 Nov 19-22
Date Detail:
Created Date:  1977-10-20     Completed Date:  1977-10-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0432324     Medline TA:  Proc Clin Dial Transplant Forum     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  13-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amphotericin B / administration & dosage,  adverse effects,  therapeutic use
Bone Marrow / drug effects
Clinical Trials as Topic
Cryptococcosis / drug therapy,  etiology*,  physiopathology
Drug Therapy, Combination
Female
Flucytosine / administration & dosage,  adverse effects,  therapeutic use
Humans
Immunosuppression / adverse effects*
Kidney / drug effects,  physiopathology
Kidney Transplantation*
Male
Middle Aged
Retrospective Studies
Transplantation, Homologous
Chemical
Reg. No./Substance:
1397-89-3/Amphotericin B; 2022-85-7/Flucytosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of hemorrhage of the digestive system with amine alpha-adrenergic stimulants
Next Document:  Relationship of renal transplantation to hypertension in chronic renal failure.